This is the fifthLive Round Table about the CO2RT – CO2 Right Technique, held on June 18, 2020.
Dr. Mariano Palena and Prof. Matteo Tozzi led an exclusive discussion about Contrast Induced Nephropathy risk:
– AV access with Automated CO2 Angiography
– how to preserve kidney function even in patients in dialysis.
00:05 – Agenda
00:49 – ACDA for AVF access (Dr. Tozzi)
2:42 – Case presentation #1
6:35 – Case presentation #2
7:44 – Case presentation #3
10:31 – Advantages of the ACDA
10:53 – Vessel Sizing with CO2 Angiography
11:51 – Take home messages
13:00 – Use of CO2 Angiography in AVF
15:10 – CIN risk and ACDA in CLI patients (Dr. Palena)
18:32 – Cost data parameters to assess the economic burden of CIN
20:17 – Case presentation #4
22:51 – Case presentation #5
25:28 – Advantages of the ACDA
26:45 – Question #1 (poll): Why is better to avoid using ICM in patients on hemodialysis?
27:46 – Question #2 (poll): Which is your anatomical district of choice for the investigation with CO2?
30:15 – Question #3 (poll): Which value of creatinine do you consider as a threshold to choose CO2 as the main contrast agent?
33:00 – Question #4 (poll): Why not using CO2 as first imaging option?
33:28 – Consideration on costs: CO2 vs ICM
34:24 – Prof. Tozzi, in your opinion how many patients can we save from Iodine if we consider RRF? Could be more than what we believe?
36:05 – What are the most important image processing features of CO2 imaging: Inversion scale, Roadmap, Bolus chase, peak of opacification or any other?
37:41 – Would you please speak about the safety of using CO2 on dialysis patients, especially for fistulography or central vein angiography in case of ICM hypersensitivity?
39:20 – Final Remarks
This is the second Live Round Table about the CO2RT – CO2 Right Technique, the First Virtual Live...